Clinical Trials Browser

Phase 1/2 × Recruiting × Uterine Neoplasms × Clear all

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05559879 2026-04-15

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

Phase 1/2 Recruiting

37 enrolled

Gynecologic

Carcinoma, Uterine Neoplasms, Endometrial Neoplasms

NCT06040970 2025-12-02

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

Phase 1/2 Recruiting

54 enrolled

Gynecologic

Ovarian Neoplasms, Uterine Neoplasms

NCT03476681 2025-04-24

Study of NEO-201 in Solid Tumors Expansion Cohorts

Phase 1/2 Recruiting

121 enrolled

GynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Uterine Neoplasms

Clinical Trials

RAINFOL-01

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

Study of NEO-201 in Solid Tumors Expansion Cohorts